Subvolts take Biohub uses AI to model biology and design proteins, aiming to cure disease. Jun 10, 2026
For you
Developers
Learn about open-source tools for protein and antibody design that could accelerate biological research.
Business
Understand how large-scale, nonprofit initiatives are using AI to tackle major scientific challenges.
Hype note
4/5Big

This episode features founders of a major research initiative discussing their ambitious goals and new AI tools for biology.

Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives

56 min Interview Hosts: Sarah Guo, Elad Gil
0:0056:20

Audio streams from Conviction. Your place is remembered on this device.

From Subvolts

Summary and analysis by Subvolts editorial, AI-assisted.

Summary

This No Priors podcast episode features Mark Zuckerberg, Priscilla Chan, and Alex Rives discussing Biohub's mission to cure disease. They cover their $500 million initiative integrating AI with wet-lab biology to create predictive cell and protein models. The conversation also touches on their new open-source protein design engine, ESMFold2, and their nonprofit structure.

Explained simply

Imagine building a super-smart computer model of how our bodies work, down to tiny cells. Biohub is doing this with AI to understand and eventually fix diseases. This could help doctors treat people much more precisely.

Why listen

This episode offers insight into how frontier AI is being applied to complex biological problems, a key area for major AI labs. Listeners will learn about Biohub's ambitious goals, their approach to building predictive biological models, and the potential for AI to accelerate scientific discovery. It's for anyone interested in the intersection of AI and life sciences, particularly how large-scale research initiatives are leveraging AI advancements.

On the mic
  • HostSarah Guo
  • HostElad Gil
  • GuestMark ZuckerbergCo-founder, Biohub
  • GuestPriscilla ChanCo-founder, Biohub
  • GuestAlex RivesHead of Science, Biohub
About
Key facts
  • Guest: Mark Zuckerberg, Priscilla Chan, Alex Rives
  • Show: No Priors
  • Length: 56 minutes
  • Biohub Initiative Funding: $500 million
  • Biohub Goal: Cure, prevent, and manage all disease by the end of the century
  • New Product: ESMFold2
Show notes from Conviction

Biohub started with an ambitious goal of curing, preventing, and managing all disease by the end of the century. A decade later, thanks to the convergence of frontier AI and biological data, that goal may have been too conservative. In this episode, Elad Gil and Sarah Guo sit down with Biohub co-founders Mark Zuckerberg and Priscilla Chan, alongside Biohub Head of Science Alex Rives. Together, they discuss Biohub’s $500 million virtual biology initiative, which integrates frontier AI with wet-lab work to build predictive world models of cells, proteins, and systems. They also talk about their newly announced open-source engine for digital protein and antibody design, ESMFold2; why Biohub is a nonprofit rather than a venture-backed startup; and how hierarchical simulations will soon allow doctors to treat patients at an individual, mechanistic level.  

Sign up for new podcasts every week. Email feedback to show@no-priors.com

Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @Biohub | @finkd | @alexrives | @ChanZuckerberg

Chapters:

00:00 – Cold Open

01:02 - Mark Zuckerberg, Priscilla Chan, and Alex Rives Introduction

01:26 – Why Biohub and Their Mission

08:27 – Integrating Frontier AI and Frontier Biology

09:45 – Micro to Macro Biological Modeling

14:22 – Mechanistic Interpretiability 

16:58 – Why Biohub is a Non-Profit

21:41 – Understanding How Biology Works

24:23 – Timeline for Curing All Diseases

26:25 – Translating Research to Patient Impact

28:04 – Launch of ESMFold2

32:13 – Tackling Off-Target Effects and Edge Cases

38:39 – Putting the Tech in Individual Hands

41:06 – Talent at Biohub

44:25 – What’s Next After ESMFold2

46:10 –  Connecting ESMFold2 to Agentic Systems

46:51 – The Virtual Cell

49:33 – Defining Success for Biohub

51:52 – Biohub Strategy Update

56:20 – Conclusion


Jargon decoded
wet-lab
Alex Rives
biological experiments done in a laboratory
mechanistic level
Alex Rives
understanding the precise biological processes involved
Published
Show
No Priors · Conviction
Length
56 min
Companies
Meta
Products
ESMFold2
Summary by
Subvolts, using an AI model (how we work). Spotted a mistake? Tell us.

Same guests, other shows

Questions people ask

What is Biohub's main goal?
Biohub aims to cure, prevent, and manage all diseases by the end of the century, leveraging frontier AI and biological data.
What is ESMFold2?
ESMFold2 is Biohub's newly announced open-source engine for digital protein and antibody design.

Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to Conviction.